212 related articles for article (PubMed ID: 19960397)
1. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
Clevert DA; Jung EM; Stock KF; Weckbach S; Feuerbach S; Reiser M; Jung F
Z Gastroenterol; 2009 Dec; 47(12):1195-202. PubMed ID: 19960397
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study.
Jung EM; Clevert DA; Schreyer AG; Schmitt S; Rennert J; Kubale R; Feuerbach S; Jung F
World J Gastroenterol; 2007 Dec; 13(47):6356-64. PubMed ID: 18081224
[TBL] [Abstract][Full Text] [Related]
3. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
[TBL] [Abstract][Full Text] [Related]
4. Improving the follow up after EVAR by using ultrasound image fusion of CEUS and MS-CT.
Clevert DA; Helck A; D'Anastasi M; Gürtler V; Sommer WH; Meimarakis G; Weidenhagen R; Reiser M
Clin Hemorheol Microcirc; 2011; 49(1-4):91-104. PubMed ID: 22214681
[TBL] [Abstract][Full Text] [Related]
5. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
[TBL] [Abstract][Full Text] [Related]
7. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced endoscopic ultrasound with low mechanical index: a new technique.
Dietrich CF; Ignee A; Frey H
Z Gastroenterol; 2005 Nov; 43(11):1219-23. PubMed ID: 16267707
[TBL] [Abstract][Full Text] [Related]
9. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
[TBL] [Abstract][Full Text] [Related]
10. Hepatic perfusion disorder associated with focal liver lesions: contrast-enhanced US patterns--correlation study with contrast-enhanced CT.
Zhou X; Luo Y; Peng YL; Cai W; Lu Q; Lin L; Sha XX; Li YZ; Zhu M
Radiology; 2011 Jul; 260(1):274-81. PubMed ID: 21467250
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatic metastases from colorectal cancer: prospective evaluation of gray scale US versus SonoVue® low mechanical index real time-enhanced US as compared with multidetector-CT or Gd-BOPTA-MRI.
Cantisani V; Ricci P; Erturk M; Pagliara E; Drudi F; Calliada F; Mortele K; D'Ambrosio U; Marigliano C; Catalano C; Marin D; Di Seri M; Longo F; Passariello R
Ultraschall Med; 2010 Oct; 31(5):500-5. PubMed ID: 20408122
[TBL] [Abstract][Full Text] [Related]
12. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
13. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
15. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
Jung EM; Clevert DA; Rupp N
Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves.
Gauthier TP; Chebil M; Peronneau P; Lassau N
Ultrasonics; 2012 Jan; 52(1):12-9. PubMed ID: 21722933
[TBL] [Abstract][Full Text] [Related]
17. Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT.
Passamonti M; Vercelli A; Azzaretti A; Rodolico G; Calliada F
Radiol Med; 2005 Apr; 109(4):358-69. PubMed ID: 15883520
[TBL] [Abstract][Full Text] [Related]
18. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of a high-end ultrasound system with a spiral CT scanner in screening for liver metastases].
Seemann MD; Bonél H; Wintersperger B; Herrmann K; Sittek H; Reiser MF
Ultraschall Med; 1998 Aug; 19(4):164-7. PubMed ID: 9816620
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis of focal liver lesions in signal-enhanced ultrasound using BR 1, a second-generation ultrasound signal enhancer.
Peschl R; Werle A; Mathis G
Dig Dis; 2004; 22(1):73-80. PubMed ID: 15292698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
